Endorectal ultrasound in evaluation on mesorectal fascia invasion in preoperative rectal cancer
10.13929/j.1003-3289.201702091
- VernacularTitle:经直肠超声术前评估直肠癌累及直肠系膜筋膜
- Author:
Xiaoyin LIU
;
Guangjian LIU
;
Zhiyang ZHOU
;
Xiaochun MENG
;
Yanling WEN
;
Junli YU
;
Yao CHEN
;
Wenjie CHENG
;
Si QIN
;
Fei CAO
;
Wenjing ZHANG
;
Qingling JIANG
;
Yimin WANG
- Keywords:
Ultrasonography;
Endorectal;
Rectal neoplasmas;
Mesorectal fascia
- From:
Chinese Journal of Medical Imaging Technology
2017;33(9):1357-1361
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the value of endorectal ultrasonography (ERUS) in assessment of mesorectal fascia (MRF) invasion in rectal cancer.Methods Data of 44 patients who accepted preoperative ERUS and total mesorectal excision surgery within a week were retrospective analyzed.There were 18 patients who accepted preoperative neoadjuvant chemotherapy and 26 patients didn't acceped.Taking the pathological diagnosis of circumferential resection margin (CRM) as the gold standard,the diagnostic efficiency of ERUS for the MRF invasion in rectal cancer was evaluated.Results The final pathological T staging was T1 in 2 cases,T2 in 17 cases and T3 in 25 cases.There were 2 cases of CRM positive results,and 42 cases of CRM negative results.With regard to the location of tumor,there were 16 cases located in low,and 28 cases in mid rectum.There were 26 cases located in anterior or antero-lateral wall of rectum,13 cases in posterior or postero-lateral wall,and 5 cases with a circle of rectum.The diagnostic accuracy were 83.33 ％ (15/18) and 92.31％ (24/26) for cases of accepting and not accepting the preoperative neoadjuvant chemotherapy;80.77％ (21/26) for cases located in anterior or antero-lateral wall,and 100％ (13/13) for cases located in posterior or postero-lateral wall;75.00％ (12/16)and 96.43 ％ (27/28) for low position and mid position tumors.The total diagnostic accuracy was 88.64％ (39/44).Conclusion ERUS can be an effective method in preoperative assessment of the MRF invasion in rectal cancer.
